PFIZER INC Effective Income Tax Rate Reconciliation Fdii Percent
PFIZER INC (PFE) reported Effective Income Tax Rate Reconciliation Fdii Percent of 2.30% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent · last filed 2026-02-26
- PFIZER INC effective income tax rate reconciliation fdii percent for fiscal 2025 was 2.30%, a 91.67% increase from fiscal 2024.
- PFIZER INC effective income tax rate reconciliation fdii percent for fiscal 2024 was 1.20%, a 96.37% decline from fiscal 2023.
- PFIZER INC effective income tax rate reconciliation fdii percent for fiscal 2023 was 33.10%, a 1642.11% increase from fiscal 2022.
- PFIZER INC effective income tax rate reconciliation fdii percent for fiscal 2022 was 1.90%, a 216.67% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation Fdii Percent 12 month |
|---|---|
| 2025-12-31 | 2.30% 10-K · filed 2026-02-26 |
| 2024-12-31 | 1.20% 10-K · filed 2026-02-26 |
| 2023-12-31 | 33.10% 10-K · filed 2026-02-26 |
| 2022-12-31 | 1.90% 10-K · filed 2025-02-27 |
| 2021-12-31 | 0.60% 10-K · filed 2024-02-22 |
| 2020-12-31 | 0.00% 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |